FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2025
Back to search
Official data from USPTO
IMMUNEBIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 35, 42
Filing date
10/06/2023
Registration date
03/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
SE
Examiner
POWERS, ALEXANDER L
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of three parallel vertical lines in grey with three fully shaded ovals on each line such that the ovals appearing in blue form a circle across the three lines and the remaining ovals appear in grey forming a diagonal pattern across the circle, all to the left of the term "IMMUNEBIOTECH", with "IMMUNE" appearing in blue and "BIOTECH" in grey.
Holders and representatives
Holders
ImmuneBiotech Medical Sweden AB
Representatives
Bradley D. Crose Crose Law LLC
Technical classification
Nice Classes
Class 1Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Bacteriological preparationsother than for medical and veterinary use; ferments for industrial purposesprobiotic bacteria for use in the manufacture of food supplements
Class 5
Probiotic bacterial formulations for medical use; probiotic supplements; food supplements; bacteriological preparations for medical purposes; probiotic preparations for medical use to help maintain a natural balance of the flora of the digestive system; pharmaceutical preparations treating and preventing conditions associated with gastrointestinal disorders; dietic preparations adapted for medical and pharmaceutical purposesprobiotic bacterial and bacterial cultures
Class 35
Business management; business administration; providing office functions; sales promotion; procurementpurchasing promotional keychainspenscups for others; market research and market analysis; business and business organisational consultancy; business administration consultancy; advertising; providing on-line consumer information concerning healthbacteriological preparationspharmaceutical preparationsimmunologyprobiotics; systemization of information into computer databases; retail store services featuring bacteriological preparations and pharmaceutical preparations
Class 42
Product research and development services; biochemical research and development; research and development services in the field of bacteriology; pharmaceutical research and developmentproviding of information and data relating to medical research and development
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/19/2025
FIMP
FINAL DISPOSITION PROCESSED
09/18/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/11/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/24/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/24/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2025
PUBO
PUBLISHED FOR OPPOSITION
01/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2024
RFNT
REFUSAL PROCESSED BY IB
07/15/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/26/2024
RFRR
REFUSAL PROCESSED BY MPU
06/26/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/14/2024
CNRT
NON-FINAL ACTION WRITTEN
06/04/2024
DOCK
ASSIGNED TO EXAMINER
05/27/2024
MAFR
APPLICATION FILING RECEIPT MAILED
01/30/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/26/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/25/2024
Continuous trademark protection
Get notified about every new filing that threatens IMMUNEBIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.